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E-mail address: nathalie.lamarche@mcgill.ca (N. LaThe small GTPases Rac1 and Cdc42 are key regulators of the cytoskeleton. We have previously iden-
tiﬁed the endocytic protein Intersectin as a binding partner and regulator of Cdc42 GTPase-activat-
ing protein (CdGAP) with activity towards Rac1 and Cdc42. This interaction is mediated through the
SH3D domain of Intersectin and the central domain of CdGAP, which does not contain any typical
proline-rich domain or known SH3-binding motif. Here, we have characterized the Intersectin-
SH3D/CdGAP interaction. We show that Intersectin-SH3D interacts directly with a small region of
CdGAP highly enriched in basic residues and comprising a novel conserved xKx(K/R)K motif.
Structured summary of protein interactions:
Intersectin physically interacts with cdGAP by pull down (View interaction)
cdGAP binds to Intersectin by peptide array (View interaction)
Intersectin binds to cdGAP by pull down (View interaction)
Intersectin physically interacts with ARHGAP30 by pull down (View interaction).
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The Rho family of small GTPases, including Cdc42, Rac1, and
RhoA, controls a wide variety of cellular processes ranging from
cell proliferation, polarization, motility, and adhesion to intracellu-
lar membrane trafﬁcking [1]. These proteins function as molecular
switches that cycle between an active GTP-bound and an inactive
GDP-bound form. Three families of regulators tightly regulate this
cycle. Guanine nucleotide exchange factors (GEFs) activate GTPases
by inducing the exchange of GDP for GTP, whereas guanine nucle-
otide dissociation inhibitors sequester and maintain inactive Rho
GTPases in the cytoplasm [2]. GTPase-activating proteins (GAPs)
increase the intrinsic GTPase activity, leading to inactivation of
Rho GTPases [2,3].
CdGAP (Cdc42 GTPase-activating protein) promotes the inacti-
vation of Rac1 and Cdc42 but not RhoA [4]. It comprises a N-termi-
nal GAP domain, a basic-rich (BR) central region, and a proline-rich
domain (PRD) with an extended C-terminal domain [20]. We have
previously identiﬁed CdGAP as a binding partner of the endocytic
scaffolding protein Intersectin involved in clathrin-mediated
endocytosis and cell signalling [5]. Intersectin is composed ofchemical Societies. Published by E
Street, Montreal, QC, Canada
marche-Vane).two N-terminal Eps-homology (EH) domains, a putative coil-coiled
domain and ﬁve C-terminal SH3 domains (SH3 A–E) [6]. Its neuro-
nal splice-variant, Intersectin-1L, contains an additional GEF do-
main active towards Cdc42, followed by a C2 domain [7].
Intersectin is targeted to clathrin-coated pits through the interac-
tion of its EH domains with epsin [8]. Additionally, it can bind to
various endocytic and signalling proteins, including dynamin, syn-
aptojanin, Sos1, Numb, Wiskott-Aldrich syndrome protein (WASP),
and CdGAP through a subset of its SH3 domains [7–12]. Interest-
ingly, we have previously found that the SH3D of Intersectin neg-
atively regulates the GAP activity of CdGAP in vitro [5]. Although
CdGAP-PRD is required for the regulation of its GAP activity by
Intersectin, this domain does not mediate CdGAP-Intersectin-
SH3D interaction. In fact, Intersectin-SH3D interacts with the cen-
tral region, lacking the conventional class I ([R/K]xXPxXP) or class
II (XPxXPx[R/K]) SH3 binding motifs or other known SH3 binding
motifs [13–18]. Therefore, we sought to determine which residues
of CdGAP are responsible for the interaction with Intersectin-SH3D.
In this study, we demonstrate that Intersectin-SH3D directly
associates with the BR region of CdGAP through a novel conserved
SKSKK motif. This BR region is evolutionary conserved within
CdGAP closest homologs and we show that the CdGAP-related
protein ARHGAP30 is also able to interact with Intersectin-SH3D.
Furthermore, the SKSKK motif is essential to CdGAP activity in
vitro.lsevier B.V. All rights reserved.
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2.1. Plasmids
CdGAP constructs and pGEX4T1-actopaxin (provided by
Dr. Chris Turner, SUNY, Syracuse, NY) were described elsewhere
[5,19,20]. CdGAP deletion mutants were introduced into BamHI/
XbaI of pRK5myc. For S35-methionine in vitro translation, CdGAP-
(1–515) was subcloned into BamHI/XbaI of pCDNA3.1. The SH3D
domain of mouse Intersectin (a.a. 1070–1131) was subcloned into
BamHI/NotI of pGEX-4T3. ARHGAP30 and ARHGAP30 deletion mu-
tants were ampliﬁed by polymerase chain reaction (PCR) using
mouse ARHGAP30 cDNA (MGC:99989, Mammalian Gene Collec-
tion, NIH) and subcloned into BamHI/XbaI of pRK5myc. CdGAP
point mutants were generated by a two-step overlap extension
PCR strategy using pRK5myc-CdGAP-(1–515) as a template and
according to standard protocols. The PCR fragments were sub-
cloned into BamHI/XbaI of pRK5myc or into Cla1 of pEGFPC1-
CdGAP (1–820). All plasmids were veriﬁed by sequencing.
2.2. Cell culture and transfection
HEK293 cells were cultured in Dulbecco’s Modiﬁed Eagle Med-
ium supplemented with 10% fetal bovine serum and antibiotics
and maintained in a 5% CO2 humidiﬁed environment at 37 C. Cells
were transfected with linear polyethylenimine (PEI) MW 25 000
(Polysciences) using a 1:5 ratio (DNA: PEI) or by calcium phosphate
[21].
2.3. GST pull-down assay
GST, GST-SH3D, and GST-actopaxin proteins were puriﬁed as
previously described [5,19]. HEK293 cells transfected with the
various plasmids were lysed in 20 mM HEPES pH 7.4 and 1% Triton
X-100 supplemented with 5 mM Na3VO4, 5 mM NaF, 1 mM phen-
ylmethylsulfonyl ﬂuoride (PMSF) and Complete™ protease inhibi-
tors. After a 10-min centrifugation, supernatants were incubated
with 0.6 nmol of GST or GST-SH3D and glutathione–agarose beads
for 2 h at 4 C. Samples were washed three times in lysis buffer and
bound proteins were submitted to SDS–PAGE and Western blot
analysis using anti-myc antibodies.
2.4. In vitro 35S-methionine translation
In vitro transcription and translation were performed using
TNT Quick Coupled Transcription/Translation Systems (Promega).
Brieﬂy, TNT Quick Master mix was incubated with 1 lg of pCDNA-
CdGAP(1–515) and 63 lCi of [35S]-methionine in a total volume of
50 lL at 30 C for 90 min. Fractions of the reaction mix (15 ll) were
incubated with 20 lg of GST, GST-SH3D or GST-actopaxin coupled
to glutathione–agarose beads, and GST pull-down assays were per-
formed as described above. Bound proteins were submitted to
SDS–PAGE, transferred to nitrocellulose membrane, and stained
with Coomassie Blue. 35S-methionine labelled proteins were
detected by PhosphoImager analysis (Perkin–Elmer).
2.5. Peptide overlay assay
A total of 20 overlapping 15-mer peptides corresponding to
CdGAP (249–358) were synthesized directly on a cellulose
membrane from their C-terminus (JPT Peptide Technologies GmbH,
Berlin, Germany). The membrane was washed once in 100% etha-
nol and three times in TBS buffer (50 mM Tris–HCl pH 8.0,
137 mM NaCl and 2.7 mM KCl) before incubation in blocking buffer
(BSA 2% w/v in TBS buffer). The membrane was incubatedovernight at 4 C with GST or GST-SH3D (1.4 lmol/ml) in blocking
buffer, washed in T-TBS buffer (TBS buffer supplemented with
0.05% Tween-20), and incubated with anti-GST-HRP antibody (GE
Healthcare). After several washes, the membrane was subjected
to chemiluminescent reaction using Western Lightning Plus-ECL
detection kit (Perkin–Elmer).
2.6. In vitro GAP assays
HEK293 cells were transfected with either pRK5-myc, pRK5-
mycCdGAP (1–515), pRK5-mycCdGAP(1-515)(SaSaa), pEGFPC1,
pEGFPC1-CdGAP(1-820), or pEGFPC1-CdGAP(1-820)(SaSaa) using
Lipofectamine 2000 as per manufacturer. Thirty-six hour post-
transfection, myc-tagged or GFP-tagged proteins were immunopre-
cipitated using anti-myc or –CdGAP antibodies [20] as described
previously [5]. The amount of immunoprecipitated myc-tagged
CdGAP was estimated on Coomassie Blue-stained SDS–PAGE by
comparison with different amount of puriﬁed bovine serum
albumin. Immunoprecipitated GFP-tagged CdGAP was quantiﬁed
using a Victor X3 2030 Multilabel Reader spectroﬂuorimeter
(Perkin–Elmer). According to this estimation, 500 ng of immuno-
precipitated CdGAP was used for the in vitro GAP assays, as
described previously [5].
3. Results
To investigate the interaction between CdGAP and Intersectin-
SH3D, we ﬁrst determined whether the association is direct using
an in vitro translation assay. A fragment corresponding to the N-ter-
minal 515 amino acids of CdGAP was expressed as a 35S-methio-
nine-labeled protein and incubated in a GST pull-down assay
using GST-Intersectin-SH3D or GST-actopaxin as a positive control.
The focal adhesion protein actopaxin has previously been shown to
interactwith a region of CdGAP corresponding to theﬁrst 515 amino
acids [19]. As shown in Fig. 1A, we found that CdGAP(1–515) binds
to both Intersectin-SH3Dand actopaxin but not GST, suggesting that
the interaction between CdGAP and Intersectin-SH3D is direct. To
further deﬁne the region of CdGAP binding to Intersectin-SH3D,
protein lysates of HEK293 cells expressing various myc-tagged
CdGAP deletionmutant proteinswere incubatedwith GST-Intersec-
tin-SH3D immobilized on glutathione-agarose beads (Fig. 1B and C).
We found that Intersectin-SH3D was able to interact with CdGAP-
(1–515), -(1–358), -(254–515), and -(181–358), all encompassing
the BR region of CdGAP. On the contrary, CdGAP-(1–312) and
CdGAP-(313–515) did not bind to Intersectin-SH3D. Therefore,
these results show that an intact BR region is required to mediate
the Intersectin-SH3D-CdGAP interaction.
To further deﬁne the amino acid motif within the BR region that
mediates Intersectin-SH3D/CdGAP interaction, we used a peptide
overlay assay comprising 20 overlapping peptides (15-mers),
corresponding to the amino acid sequence of the BR region (249–
358), immobilized on a cellulose membrane and incubated with
puriﬁed GST-Intersectin-SH3D or GST proteins as a negative con-
trol (Fig. 2). Interestingly, we found that 8 consecutive peptides
corresponding to residues 284–333 were able to speciﬁcally bind
to Intersectin-SH3Dwith different afﬁnities (Fig. 2). The interaction
between peptide 10 (residues 294–308) and 14 (residues 314–328)
with Intersectin-SH3D showed the strongest afﬁnity. Interestingly,
amino acid sequence analysis of the peptides revealed a common
SKSK motif, suggesting that these residues are important for the
interaction between Intersectin-SH3D and CdGAP.
Furthermore, a close analysis of the amino acid sequences of
CdGAP and its protein homologs ARHGAP30, ARHGAP32/GRIT, and
ARHGAP33/Noma-GAP revealed that the BR region is highly con-
served amongst the CdGAP-related proteins (Fig. 3A). In particular,
Fig. 1. An intact BR domain of CdGAP is required to bind to Intersectin-SH3D. (A) In vitro [35S]-methionine translated CdGAP (1–515) was incubated with GST, GST-SH3D or
GST-actopaxin coupled to glutathione-agarose beads in a GST pull down assay. 5% of the starting material (S.M.) was loaded in the ﬁrst lane. (B) Myc-tagged deletion mutants
of CdGAP expressed in HEK293 cells were incubated with GST or GST-SH3D proteins coupled to glutathione–agarose beads in a GST pull down assay. CdGAP was revealed by
western blotting using anti-myc antibodies. 2% of starting material (S.M.) was loaded in the ﬁrst lane. (C) Schematic representation of mouse full-length CdGAP (a.a. 1–1425)
and CdGAP deletion mutants. +: polybasic residue cluster, GAP: GTPase-activating Protein, BR: basic-rich, PRD: proline-rich domain.
Fig. 2. Peptide overlay assay with GST-SH3D. The C-terminus of twenty 15-mer overlapping peptides corresponding to amino acids 249–358 of CdGAP were covalently bound
to a cellulose membrane as per manufacturer. The membrane was incubated with GST or GST-SH3D proteins and bound proteins were revealed using an anti-GST-HRP
antibody. Protein sequence alignment of peptides 8–15 is shown. Two distinct SKSK motifs are highlighted in bold.
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CdGAP-related proteins (Fig. 3A). To determine whether the BR do-
main of other CdGAP-related proteins is able to interact with Inter-sectin-SH3D, we examined the interaction between Intersectin-
SH3D and ARHGAP30. Indeed, myc-tagged ARHGAP30 expressed
in HEK293 cells was able to interact with Intersectin-SH3D
Fig. 3. Intersectin-SH3D interacts with the CdGAP-related protein ARHGAP30. (A) Amino acid alignment of the BR region of mouse and human CdGAP with protein homologs.
Conserved amino acids are highlighted in bold. (B) Myc-tagged CdGAP, ARHGAP30, and ARHGAP30 deletion mutants were transiently expressed in HEK293 cells and protein
lysates were incubated with GST or GST-SH3D proteins coupled with glutathione–agarose beads. GST pull down proteins were revealed by western blotting using anti-myc
antibodies. 2% of starting material (S.M.) was loaded as a control. (C) Schematic representation of mouse full-length CdGAP (a.a. 1–1425) and ARHGAP30. +: polybasic residue
cluster, GAP: GTPase-activating protein, BR: basic-rich, PRD: proline-rich domain.
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GAP domain followed by the BR region bound to Intersectin-SH3D
whereasARHGAP30 (335–1092) lacking the BRdomainwasnot able
to interact with Intersectin-SH3D (Fig. 3B and C). Thus, these results
suggest that the conserved BR domain within CdGAP-related pro-
teins mediates the interaction CdGAP/Intersectin-SH3D.
We then performed alanine-scanning mutagenesis to identify
which residues in the BR region of CdGAP mediate the interaction
with SH3D. Based on the amino acid sequence similarity between
ARHGAP30 and CdGAP, CdGAP point mutants were generated byamino acid substitution of conserved residues (Fig. 4A). We found
that the interaction between Intersectin-SH3D and CdGAP point
mutant 2 was signiﬁcantly impaired compared with the binding
of intersectin-SH3D to other CdGAP point mutants (Fig. 4B and
C). Interestingly, this CdGAP point mutant 2 has its positively
charged lysines replaced by alanines in the ﬁrst SKSKK motif, pre-
viously identiﬁed using the peptide overlay assay (Fig. 2). However,
replacement of the lysines by alanines in the second SKSK motif
(CdGAP point mutant 7) did not alter the interaction with
Intersectin-SH3D. Altogether, these results show that the SKSKK
Fig. 4. The basic residues in the ﬁrst SKSK motif are required for the interaction between CdGAP and Intersectin-SH3D. (A) Amino acid sequence alignment of the BR domains
of CdGAP and ARHGAP30. CdGAP point mutants have been generated by alanine scanning mutagenesis based on the conserved residues between CdGAP and ARHGAP30. (B)
Myc-tagged wild-type (WT) CdGAP (1–515) and CdGAP point mutants 1–9 expressed in HEK293 cells were incubated with GST or GST-SH3D proteins coupled to glutathione-
agarose beads. Proteins speciﬁcally bound to the beads were revealed by western blotting using an anti-myc antibody. 2% of starting material (S.M.) was loaded as a control.
(C) Quantitative analysis of blots as in (B), showing the relative ratio of CdGAP point mutants bound to GST-SH3D. A ratio of bound to total proteins was calculated for each
myc-tagged protein and is represented relative to wild-type (WT) CdGAP (1–515). Error bars represent standard errors of the mean for at least ﬁve independent experiments.
P value was determined by unpaired student’s t test.
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CdGAP is a novel SH3-binding sequence that mediates the interac-
tion of CdGAP with the SH3D of Intersectin.
We then examined if the SKSKK motif is important for the reg-
ulation of CdGAP activity. In an in vitro GAP assay, [Y32P]-GTP-
loaded Rac1 was incubated with myc-tagged CdGAP(1–515) or
CdGAP(1–515) (SaSaa) immunoprecipitated from HEK293 cell
lysates. We observed a reduction in the GAP activity of CdGAP(1–
515) (SaSaa) compared with the wild-type protein (Fig. 5A).
However, when point mutations of the SKSKK motif were intro-
duced into the full length CdGAP protein (1–820), the GAP activity
of the mutant protein was inhibited (Fig. 5B). In the presence of
GST-SH3D, the GAP activity of CdGAP(1–820) was reduced aspreviously shown [5] but it has no major effect on the mutant
protein (Fig. 5C). Therefore, these results show that the SKSKK
motif is important for the regulation of CdGAP activity in vitro.
4. Discussion
In this study, we have identiﬁed key amino acid residues in-
volved in the direct binding of the SH3D domain of Intersectin with
CdGAP. These ﬁndings suggest that evolutionary conserved lysine
residues located within the BR region of CdGAP and its related pro-
tein homologs are central to a novel atypical SH3 binding motif
xKx(K/R)K. It is well established that most of the SH3 domains
characterized to date bind to conventional class I ([R/K]xXPxXP)
Fig. 5. The SKSKK motif is critical for the GAP activity of CdGAP in vitro. [c-32P]-GTP loaded Rac1 was incubated with myc-tagged immunoprecipitated CdGAP proteins (A) or
with GFP-tagged immunoprecipitated CdGAP proteins (B and C) and a GAP assay was performed. (C) The in vitro GAP assay was performed in the presence of 10 lm GST or
GST-SH3D. Error bars represent standard errors of the mean for at least three independent experiments.
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ing number of atypical motifs containing or not a proline residue
have been discovered over the past years. These include the
PxxxPR motif recognized by CIN85 in a number of proteins [15],
the PxxDY motif that associates with Eps8 SH3 domain [16], the
RKxxY motif in SKAP55 that mediates its interaction with the C-
SH3 domain of SLAP [17], and the RxxK motif in SLP-76 bound
by the C-SH3 domain of Gads [18]. Most of these motifs share with
the novel identiﬁed xKx(K/R)K motif the presence of key basic res-
idues. In contrast to other SH3 domains (A, B, C, and E) of Intersec-
tin that interact with a large number of proteins though the
consensus PXXP sequence [7–9], only CdGAP and the adaptor pro-
tein Numb have been shown to interact with the SH3D domain of
Intersectin. It is noteworthy that the C-terminus of mouse Numb
involved in the interaction with Intersectin-SH3D [11] also con-
tains the residues SKSKQ, adding support to the ﬁndings that the
novel xKx(K/R)K motif mediates the interaction with Intersectin-
SH3D. Although the peptide overlay assay suggests that the second
SKSK motif may be involved in the CdGAP/Intersectin-SH3D inter-
action (Fig. 2), the alanine scanning mutagenesis experiment
shows that only the ﬁrst SKSKK motif is essential to mediate the
interaction with SH3D (Fig. 4). In this experiment, CdGAP proteins
expressed in HEK293 cells may have post-translational modiﬁca-
tions, absent in the synthesized peptides, that could alter the inter-
action with SH3D and account for the discrepancy between the
two results. In support of these ﬁndings, we demonstrate that
the critical SKSKK motif regulates the GAP activity of CdGAP
in vitro. Indeed, the replacement of the lysine residues by alaninesin the full-length protein CdGAP (1–820) is sufﬁcient to inhibit the
GAP activity. Interestingly, point mutations of the SKSKK motif in
the shorter protein CdGAP(1–515) lacking the PRD slightly affect
the GAP activity, suggesting that the PRD is required for this regu-
lation. These data are in good agreement with our previous study
showing that the PRD of CdGAP is required for Intersectin-medi-
ated regulation of CdGAP activity [5].
In addition, it has been reported that the SH3 domains of Inter-
sectin-1L regulate the GEF activity of Intersectin towards Cdc42
through intramolecular interactions with the adjacent DH-PH-C2
domains that do not involve proline peptide binding [11,22]. The
interaction of Numb with Intersectin-SH3D relieves this autoinhib-
itory mechanism, resulting in a net activation of Cdc42 activity
[11]. It will be of interest to determine whether CdGAP binding
to the SH3D domain of Intersectin can also act as a positive regu-
lator of the GEF activity of Intersectin-1L towards Cdc42. Combined
with the negative regulation of CdGAP activity by Intersectin SH3
domains [5], these SH3 interactions would result in a net activation
of Cdc42 activity. Future studies will determine how these molec-
ular interactions are orchestrated in a spatial and temporal manner
to affect Cdc42 activity in a physiological context.
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